Patient and Disease Characteristics Summary
| Group A | Group B | Group B1 | Group B2 | |
|---|---|---|---|---|
| No. of patients | 54 | 53 | 40 | 13 |
| Demographics | ||||
| Age (y [mean]) | 63.3 | 57.8 | 50.0 | 60.3 |
| Race | ||||
| White | 24 | 33 | 26 | 7 |
| African American | 29 | 16 | 11 | 5 |
| Hispanic | 1 | 3 | 2 | 1 |
| Other | 0 | 1 | 1 | 0 |
| Prostatectomy findings | ||||
| T stage | ||||
| pT1/T2 | 10 | 16 | 10 | 6 |
| pT3 | 42 | 32 | 26 | 6 |
| pT4 | 2 | 3 | 2 | 1 |
| pTx | 0 | 2 | 2 | 0 |
| Gleason score (GS) | ||||
| GS 5 | 4 | 3 | 2 | 1 |
| GS 6 | 15 | 12 | 7 | 5 |
| GS 7 | 20 | 27 | 21 | 6 |
| GS 8 | 4 | 5 | 5 | 0 |
| GS 9 | 5 | 4 | 3 | 1 |
| Not recorded | 6 | 2 | 3 | 0 |
| Margins | ||||
| Positive | 40 | 28 | 19 | 9 |
| Negative | 12 | 23 | 19 | 4 |
| Not recorded | 2 | 2 | 2 | 0 |
| Seminal vesicle inv. | ||||
| Positive | 15 | 15 | 13 | 2 |
| Negative | 37 | 36 | 25 | 11 |
| Not recorded | 2 | 2 | 2 | 0 |
| Extracaps. extension | ||||
| Yes | 33 | 32 | 26 | 6 |
| No | 20 | 19 | 12 | 7 |
| Not recorded | 1 | 2 | 2 | 0 |
| Lymph nodes inv. | ||||
| No | 42 | 47 | 37 | 10 |
| Yes | 4 | 0 | 0 | 0 |
| Not sampled | 8 | 6 | 3 | 3 |
| Post-RRP PSA nadir | ||||
| PSA ≤ 0.1 | 22 | 28 | 19 | 9 |
| 0.1 < PSA ≤ 0.2 | 10 | 6 | 5 | 1 |
| 0.2 < PSA ≤ 0.3 | 3 | 11 | 10 | 1 |
| 0.3 < PSA ≤ 0.5 | 6 | 1 | 1 | 0 |
| 0.5 < PSA ≤ 1.0 | 5 | 5 | 4 | 1 |
| 1.0 < PSA | 7 | 2 | 1 | 1 |
| Not recorded | 1 | 1 | 1 | 0 |
| Highest PSA post-RRP | ||||
| PSA ≤ 0.1 | 13 | 7 | 3 | 4 |
| 0.1 < PSA ≤ 0.2 | 8 | 7 | 5 | 2 |
| 0.2 < PSA ≤ 0.3 | 4 | 5 | 5 | 0 |
| 0.3 < PSA ≤ 0.5 | 6 | 6 | 5 | 1 |
| 0.5 < PSA ≤ 1.0 | 9 | 12 | 9 | 3 |
| 1.0 < PSA ≤ 2.0 | 7 | 11 | 10 | 1 |
| 2.0 < PSA | 6 | 5 | 3 | 2 |
| Not recorded | 1 | 0 | 0 | 0 |
| RRP-to-RT interval (d) | ||||
| Mean | 352 | 564 | 544 | 573 |
T = tumor; inv. = invasion; Extracaps. = extracapsular.